Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops and sells pharmaceuticals and medical devices

Photocure ASA engages as a pharmaceutical company, which engages in the provision of photodynamic diagnosis and treatment.

It operates through Commercial Franchise and Development Portfolio segments.

The Commercial Franchise segment includes Hexvix/Cysview products and is broken down into own and partner sales.

The Development Portfolio segment offers development of commercial products and pipeline
products.

The company was founded on August 27, 1993 and is headquartered in Oslo, Norway.
Sales per Businesses
20142015Delta
NOK (in Million)%NOK (in Million)%
Cancer92.0171.4%---
Dermatology1.571.2%---
Commercial Franchise--134.72100%-
Sales per Regions
20142015Delta
NOK (in Million)%NOK (in Million)%
Partner Countries Europe47.8937.1%60.6545% +26.63%
Nordic Countries33.4225.9%38.6728.7% +15.72%
United States12.289.5%23.0217.1% +87.47%
Managers
NameAgeSinceTitle
Kjetil Hestdal MD, PhD571997President, Chief Executive Officer & Media Contact
Bente-Lill B. Romøren682014Chairman
Erik Dahl-2012Chief Financial Officer & IR Contact
Inger Ferner Heglund622006Vice President-Research & Development
Xavier Denis Yon772011Independent Director
Synne Hermansen Røine, MBA382014Independent Director
Tom Edward Pike57-Independent Director
Lars Rønn53-Independent Director
Grete Hogstad612005Vice President-Strategic Marketing
Gry Stensrud, PhD472006VP-Technical Development & Operations
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 21,557,910 15,233,190 70.7% 809 0.0% 70.7%
Shareholders
NameEquities%
Alexander Brask Hansson 3,230,000 15.0%
KLP Kapitalforvaltning AS 1,410,610 6.54%
Fondsfinans Kapitalforvaltning ASA 1,340,003 6.22%
Radiumhospitalets Forskningsstiftelse 1,077,416 5.00%
Hunter Hall Investment Management Ltd. 859,976 3.99%
Danske Capital AS 857,451 3.98%
Eika Kapitalforvaltning AS 366,001 1.70%
Skagen AS 299,104 1.39%
Polar Capital LLP 254,476 1.18%
Kjetil Hestdal, MD, PhD 133,873 0.62%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
PHOTOCURE ASA-23.81%88
JOHNSON & JOHNSON6.67%333 142
ROCHE HOLDING LTD.8.21%220 797
PFIZER INC.3.88%200 926
NOVARTIS AG-1.08%195 490
MERCK & CO., INC.5.55%170 359
SANOFI10.33%119 103
GLAXOSMITHKLINE PLC0.22%99 735
BAYER AG6.12%97 670
ELI LILLY AND CO13.42%92 042
BRISTOL-MYERS SQUIBB C..-8.37%88 224
ALLERGAN PLC12.84%79 506
ABBOTT LABORATORIES14.89%76 257
ASTRAZENECA PLC5.07%75 602
NOVO NORDISK A/S-1.96%73 527
SHIRE PLC-3.98%53 018
TAKEDA PHARMACEUTICAL ..9.99%38 151
TEVA PHARMACEUTICAL IN..-17.57%32 039
ASTELLAS PHARMA INC-4.67%30 296
MYLAN NV-1.78%20 065
CHUGAI PHARMACEUTICAL ..16.54%19 864
Sector Pharmaceuticals - NEC
Photocure ASA : Connections
Europharma Apotek AS
Radiumhospitalets Forskningsstiftelse
Vaccibody AS
ClanoTech AB
Chester Valley Pharmaceuticals, Inc.
Goapharma SAS
Michelson Diagnostics Ltd.
Acd Pharmaceuticals AS
Medical Instill Technologies, Inc
Credio as
Pressalit A/S
Biosergen AS
Laboratoires Panpharma SA
Elastagen Pty Ltd.
Triax A/S
Company contact information
Photocure ASA
Hoffsveien 4
Oslo 0275

Phone : +47.22.06.22.10
Fax : +47.22.06.22.18
Web : www.photocure.com
© 2017 People , Fundamentals and Ownership